http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107375311-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 |
| filingDate | 2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107375311-B |
| titleOfInvention | Pharmaceutical use of liquiritin for treating neuropathic pain |
| abstract | The experimental result of the invention shows that when the liquiritin (L iquitinin) is used in the safe dose range, the liquiritin with the dose of 120mg/kg can obviously relieve the allodynia and hyperalgesia induced by a chronic compressive injury model of sciatic nerve, improve the histopathological change of sciatic nerve and regulate the protein expression of inflammatory cytokines, and proves that the liquiritin has the effects of relieving the neuropathic pain caused by the chronic compressive injury of mice and promoting the functional recovery of nerves. |
| priorityDate | 2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.